AU2156800A - Oral antiestrogen pharmaceutical composition - Google Patents

Oral antiestrogen pharmaceutical composition

Info

Publication number
AU2156800A
AU2156800A AU21568/00A AU2156800A AU2156800A AU 2156800 A AU2156800 A AU 2156800A AU 21568/00 A AU21568/00 A AU 21568/00A AU 2156800 A AU2156800 A AU 2156800A AU 2156800 A AU2156800 A AU 2156800A
Authority
AU
Australia
Prior art keywords
antiestrogen
oral
pharmaceutical composition
pharmaceutical
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU21568/00A
Inventor
Frank Everett Bowen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AU2156800A publication Critical patent/AU2156800A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4433—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU21568/00A 1998-12-18 1999-12-16 Oral antiestrogen pharmaceutical composition Abandoned AU2156800A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21643198A 1998-12-18 1998-12-18
US09216431 1998-12-18
PCT/US1999/027933 WO2000037083A1 (en) 1998-12-18 1999-12-16 Oral antiestrogen pharmaceutical composition

Publications (1)

Publication Number Publication Date
AU2156800A true AU2156800A (en) 2000-07-12

Family

ID=22807038

Family Applications (1)

Application Number Title Priority Date Filing Date
AU21568/00A Abandoned AU2156800A (en) 1998-12-18 1999-12-16 Oral antiestrogen pharmaceutical composition

Country Status (3)

Country Link
AR (1) AR021719A1 (en)
AU (1) AU2156800A (en)
WO (1) WO2000037083A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ297446B6 (en) * 2004-09-30 2006-12-13 Pliva - Lachema A. S. Process for preparing oral solid medicamentous form and oral medicamentous form prepared thereby
EP3205648A1 (en) 2010-06-10 2017-08-16 Seragon Pharmaceuticals, Inc. Estrogen receptor modulators and uses thereof
EA029559B1 (en) 2011-12-14 2018-04-30 Серагон Фармасьютикалс, Инк. Fluorinated estrogen receptor modulators and use thereof
CA2857061A1 (en) 2011-12-16 2013-06-20 Olema Pharmaceuticals, Inc. Novel benzopyran compounds, compositions and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6060503A (en) * 1991-12-02 2000-05-09 Endorecherche, Inc. Benzopyran-containing compounds and method for their use
US5726186A (en) * 1995-09-08 1998-03-10 Eli Lilly And Company Pentacyclic compounds, intermediates, processes, compositions, and methods
US6465445B1 (en) * 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors

Also Published As

Publication number Publication date
AR021719A1 (en) 2002-07-31
WO2000037083A1 (en) 2000-06-29

Similar Documents

Publication Publication Date Title
HK1041224A1 (en) New pharmaceutical formulation
HU9901606D0 (en) Pharmaceutical compositions
GB9827996D0 (en) Pharmaceutical Compositions
PT1466615E (en) Pharmaceutical composition
AU4143999A (en) Oral composition comprising capsules
AU1887401A (en) Medicinal composition
HUP0103924A3 (en) Oral pharmaceutical compositions containing buprenorphin
PL343769A1 (en) Pharmaceutical composition
AU5565099A (en) Pharmaceutical compositions and methods for use
AU4428000A (en) Pulse-delivery oral compositions
GB9818591D0 (en) Pharmaceutical composition
GB9809213D0 (en) Pharmaceutical compositions
AU1732401A (en) Medicinal compositions for oral use
AU2422699A (en) Oral care compositions
AUPP332898A0 (en) Pharmaceutical composition
AU5378599A (en) Oral formulation
HK1030552A1 (en) Pharmaceutical compositions
AU4910199A (en) Oral composition
AU2156800A (en) Oral antiestrogen pharmaceutical composition
AU2880699A (en) Pharmaceutical compositions and methods for use
AU5182099A (en) Pharmaceutical formulation
GB9806487D0 (en) Pharmaceutical compositions
AU5978900A (en) Oral composition comprising capsules
AU2896897A (en) Oral pharmaceutical compositions
HU9800078D0 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase